Fabrication of PLGA nanoparticles with a fluidic nanoprecipitation system

Particle size is a key feature in determining performance of nanoparticles as drug carriers because it influences circulating half-life, cellular uptake and biodistribution. Because the size of particles has such a major impact on their performance, the uniformity of the particle population is also a significant factor. Particles comprised of the polymer poly(lactic-co-glycolic acid) (PLGA) are widely studied as therapeutic delivery vehicles because they are biodegradable and biocompatible. In fact, microparticles comprised of PLGA are already approved for drug delivery. Unfortunately, PLGA nanoparticles prepared by conventional methods usually lack uniformity. We developed a novel Fluidic NanoPrecipitation System (FNPS) to fabricate highly uniform PLGA particles. Several parameters can be fine-tuned to generate particles of various sizes.

[1]  Gordon L. Amidon,et al.  Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size , 1996, Pharmaceutical Research.

[2]  J C Middleton,et al.  Synthetic biodegradable polymers as orthopedic devices. , 2000, Biomaterials.

[3]  Linbo Wu,et al.  In vitro degradation of three-dimensional porous poly(D,L-lactide-co-glycolide) scaffolds for tissue engineering. , 2004, Biomaterials.

[4]  M A Tracy,et al.  Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. , 1999, Biomaterials.

[5]  Michael J. Campolongo,et al.  Drug delivery: Old polymer learns new tracts. , 2009, Nature materials.

[6]  J. Berg Interfacial Hydrodynamics: An Over View , 1982 .

[7]  Stephanie E. A. Gratton,et al.  The effect of particle design on cellular internalization pathways , 2008, Proceedings of the National Academy of Sciences.

[8]  G. Lutz,et al.  Formulation of polylactide-co-glycolic acid nanospheres for encapsulation and sustained release of poly(ethylene imine)-poly(ethylene glycol) copolymers complexed to oligonucleotides , 2009, Journal of nanobiotechnology.

[9]  L. Scriven,et al.  Interfacial turbulence: Hydrodynamic instability and the marangoni effect , 1959 .

[10]  R. Pandey,et al.  Nanoparticle-Based Oral Drug Delivery System for an Injectable Antibiotic – Streptomycin , 2007, Chemotherapy.

[11]  Jeremy L. Steinbacher,et al.  Interfacial polymerization within a simplified microfluidic device: capturing capsules. , 2005, Journal of the American Chemical Society.

[12]  Tejraj M Aminabhavi,et al.  Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Robert Langer,et al.  Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers , 2008, Proceedings of the National Academy of Sciences.

[14]  J. Siepmann,et al.  Mathematical modeling of bioerodible, polymeric drug delivery systems. , 2001, Advanced drug delivery reviews.

[15]  M. Shive,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres , 1997 .

[16]  J. Benoit,et al.  Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility. , 2003, Biomaterials.

[17]  Q. Ping,et al.  PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies. , 2008, Drug development and industrial pharmacy.

[18]  S. Cryan,et al.  A comparative study of a range of polymeric microspheres as potential carriers for the inhalation of proteins. , 2008, International journal of pharmaceutics.

[19]  S. Feng,et al.  Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[20]  M. L. La Rotonda,et al.  Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[21]  Fakhrul Ahsan,et al.  Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses. , 2009, International journal of pharmaceutics.

[22]  Robert Langer,et al.  Microfluidic platform for controlled synthesis of polymeric nanoparticles. , 2008, Nano letters.

[23]  Fernando Albericio,et al.  Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[24]  M. R. Kumar,et al.  Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[25]  Jinsong Hua,et al.  Characterization of electrospraying process for polymeric particle fabrication , 2008 .

[26]  J. Benoit,et al.  How to achieve sustained and complete protein release from PLGA-based microparticles? , 2008, International journal of pharmaceutics.

[27]  Anderson,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres. , 1997, Advanced drug delivery reviews.

[28]  Robert Gurny,et al.  Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[29]  H. M. Nielsen,et al.  Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation , 2009, Journal of Controlled Release.

[30]  M. A. Holgado,et al.  Protein-loaded PLGA microparticles engineered by flow focusing: physicochemical characterization and protein detection by reversed-phase HPLC. , 2009, International journal of pharmaceutics.

[31]  Robert Gurny,et al.  Fluorescent biodegradable PLGA particles with narrow size distributions: preparation by means of selective centrifugation. , 2007, International journal of pharmaceutics.

[32]  Hatem Fessi,et al.  Nanocapsule formation by interfacial polymer deposition following solvent displacement , 1989 .

[33]  A. Xu,et al.  Recombinant interferon-alpha2b poly(lactic-co-glycolic acid) microspheres: pharmacokinetics-pharmacodynamics study in rhesus monkeys following intramuscular administration , 2008, Acta Pharmacologica Sinica.

[34]  T. Fahmy,et al.  Controlling the morphology of electrospray-generated PLGA microparticles for drug delivery. , 2010, Journal of colloid and interface science.

[35]  Hans P Merkle,et al.  Formulation aspects of biodegradable polymeric microspheres for antigen delivery. , 2005, Advanced drug delivery reviews.

[36]  Mauro Ferrari,et al.  Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? , 2008, Pharmaceutical Research.

[37]  V. Kanchan,et al.  Improved bioavailability of orally delivered insulin using Eudragit-L30D coated PLGA microparticles. , 2008, Journal of microencapsulation.

[38]  S. Vyas,et al.  Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. , 2006, Vaccine.